BeOne Medicines (ONC) Presents Updated BRUKINSA Phase 3 Data at EHA
BeOne Medicines Ltd. (NASDAQ:ONC) is one of the high-growth large-cap stocks to invest in. On June 11, BeOne Medicines Ltd. (NASDAQ:ONC) presented updated Phase 3 clinical data at the European Hematology Association Congress for its approved BTK inhibitor, BRUKINSA. BeOne Medicines Ltd. (ONC) Hits New Milestone on Chronic Lymphocytic Leukemia Treatment in Older Patients Dragon…
